Related Experiment Video
Updated: Apr 6, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Autotaxin Derived From Lipoprotein(a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the
Rihab Bouchareb1, Ablajan Mahmut1, Mohamed Jalloul Nsaibia1
1From Laboratoire d'Études Moléculaires des Valvulopathies (LEMV), Groupe de Recherche en Valvulopathies (GRV), Quebec Heart and Lung Institute/Research Center, Department of Surgery (R.B., A.M., M.J.N., M.-C.B., J.-L.L., M.-H.L., F.H., P.M.), Department of Medicine (A.D., P.P., B.J.A., A.M.), Department of Pathology (C.C., S.T., S.P.), and Department of Molecular Medicine (Y.B.), Laval University, Québec, Canada; and Department of Chemistry and Biochemistry, University of Windsor, Ontario, Canada (C.A.S., R.R., M.L.K.).
Lipoprotein(a) transports autotaxin (ATX) to the aortic valve, where ATX-lysophosphatidic acid promotes calcific aortic valve disease (CAVD) by driving inflammation and mineralization, suggesting a new therapeutic target.
Area of Science:
- Cardiovascular Biology
- Biochemistry
- Pathology
Background:
- Mendelian randomization studies link lipoprotein(a) [Lp(a)] to calcific aortic valve disease (CAVD).
- Lp(a) carries oxidized phospholipids, including lysophosphatidylcholine.
- Autotaxin (ATX) metabolizes lysophosphatidylcholine into lysophosphatidic acid.
Purpose of the Study:
- To investigate the role of ATX and its product, lysophosphatidic acid, in CAVD pathogenesis.
- To explore the interaction between ATX, Lp(a), and aortic valve mineralization.
Main Methods:
- Enzyme activity assays and immunohistochemistry on human aortic valves.
- In vitro studies on isolated valve interstitial cells.
- In vivo studies using a mouse model of CAVD (LDLR(-/-)/ApoB(100/100)/IGFII mice).
Main Results:
- Elevated ATX activity (60%) and expression in mineralized aortic valves compared to controls.
- ATX colocalizes with oxidized phospholipids and apolipoprotein(a) in mineralized valves.
- ATX-lysophosphatidic acid promotes valve interstitial cell mineralization via NF-κB/IL-6/BMP pathway; Lp(a) transports ATX to the valve.
Conclusions:
- ATX is delivered to the aortic valve via Lp(a) and secreted by valve interstitial cells.
- ATX-lysophosphatidic acid drives aortic valve inflammation and mineralization.
- Targeting ATX-lysophosphatidic acid presents a potential therapeutic strategy for CAVD.
Related Concept Videos
Inflammation
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Peripheral Artery Disease I: Introduction
Aortic Regurgitation I: Introduction

